HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 194 filers reported holding HERON THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.74 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $11,322 | -86.3% | 10,992 | -66.8% | 0.00% | -83.3% |
Q4 2022 | $82,750 | -79.2% | 33,100 | -64.9% | 0.01% | -80.0% |
Q3 2022 | $398,000 | +108.4% | 94,398 | +37.7% | 0.03% | +66.7% |
Q2 2022 | $191,000 | +83.7% | 68,552 | +275.9% | 0.02% | +100.0% |
Q1 2022 | $104,000 | +70.5% | 18,238 | +383.6% | 0.01% | +50.0% |
Q1 2021 | $61,000 | -51.2% | 3,771 | -29.3% | 0.01% | -50.0% |
Q4 2019 | $125,000 | +594.4% | 5,333 | +433.3% | 0.01% | +500.0% |
Q3 2019 | $18,000 | -98.4% | 1,000 | -96.6% | 0.00% | -97.4% |
Q2 2018 | $1,141,000 | +875.2% | 29,379 | +592.4% | 0.08% | +680.0% |
Q1 2018 | $117,000 | +13.6% | 4,243 | -33.7% | 0.01% | 0.0% |
Q3 2017 | $103,000 | -40.1% | 6,395 | -48.8% | 0.01% | -37.5% |
Q2 2017 | $172,000 | +2766.7% | 12,483 | +2619.6% | 0.02% | +1500.0% |
Q1 2017 | $6,000 | -93.3% | 459 | -93.3% | 0.00% | -90.0% |
Q4 2016 | $90,000 | +2150.0% | 6,891 | +3953.5% | 0.01% | +900.0% |
Q4 2015 | $4,000 | – | 170 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TANG KEVIN C | 760 | $783 | 100.00% |
Velan Capital Investment Management LP | 6,986,744 | $7,196,346 | 5.80% |
Tejara Capital Ltd | 2,109,681 | $2,172,971 | 1.23% |
JW Asset Management, LLC | 2,407,418 | $2,479,641 | 1.07% |
Rubric Capital Management LP | 26,713,503 | $27,514,908 | 1.03% |
GREAT POINT PARTNERS LLC | 4,737,368 | $4,879,489 | 0.89% |
Orchard Capital Management, LLC | 2,142,823 | $2,207,108 | 0.82% |
Clearline Capital LP | 6,149,842 | $6,334,338 | 0.54% |
CM Management, LLC | 450,000 | $463,500 | 0.49% |
JACOB ASSET MANAGEMENT OF NEW YORK LLC | 327,450 | $337,274 | 0.48% |